From Morningstar:

Granola is not just a breakfast treat, but also an investment opportunity. The GRANOLAS stocks, including GSK, Roche, AstraZeneca, and others, make up Europe’s most valuable stocks outside of tech. Novo Nordisk leads with a 71.73% return rate, driven by high demand for its diabetes and weight-loss drugs. Roche, on the other hand, has reported losses of 10.37% due to failed acquisitions and competition pressure.



Read more at Morningstar: GRANOLAS: Stock of the Week